Its leukemia-specific role in regulating oncogenic targets such as transforming acidic coiled-coil containing protein 3 (TACC3) underscores its therapeutic potential as a targetable vulnerability in acute myeloid leukemia [83]. The gene discussed is TACC3; the disease is leukemia.